Director/PDMR Shareholding

RNS Number : 2679A

GlaxoSmithKline PLC

17 February 2014

 



Notification of Transactions of Directors and Persons Discharging Managerial   Responsibility

GlaxoSmithKline Performance Share Plan

Sale of shares to meet tax liabilities

The table below sets out changes in the interests of Directors and Persons Discharging Managerial Responsibility (PDMR) in the Ordinary Shares of GlaxoSmithKline plc arising from the sale of Ordinary Shares at a fair market value price of £16.44 per Ordinary Share on 13 February 2014 to meet tax liabilities following the vesting of awards granted under the GlaxoSmithKline 2009 Performance Share Plan (PSP).

	Number of Ordinary Shares sold to meet tax liabilities following the vesting of a PSP award
Sir Andrew Witty*	92,419
Mr S Dingemans*	42,698
Mr S Bicknell	11,091
Mr A Hussain	27,238
Mr D Redfern	15,527
Ms C Thomas	21,812
Dr P Vallance	31,423

* Denotes an Executive Director

The table below sets out changes in the interests of a Director and PDMRs in the American Depositary Shares (ADS) of GlaxoSmithKline plc arising from the withholding of ADSs at a fair market value price of $54.81 per ADS on 13 February 2014 to meet tax liabilities following the vesting of awards granted under the PSP.

	Number of ADSs withheld to meet tax liabilities following the vesting of a PSP award
Dr M Slaoui*	30,818
Ms D Connelly	11,321
Mr W Louv	6,860
Mr D Troy	15,625

* Denotes an Executive Director

The Company, Directors and PDMRs were advised of these transactions on 17 February 2014.

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

Sonja Arsenić

Corporate Secretariat

17 February 2014

 

END

 

 

RDSQDLFFZLFBBBQ